Kodiak Sciences (KOD) Competitors $4.53 +0.04 (+0.89%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$4.58 +0.05 (+1.10%) As of 07/11/2025 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KOD vs. GHRS, CRMD, IMNM, SNDX, KALV, REPL, XERS, VIR, PHAR, and GYREShould you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include GH Research (GHRS), CorMedix (CRMD), Immunome (IMNM), Syndax Pharmaceuticals (SNDX), KalVista Pharmaceuticals (KALV), Replimune Group (REPL), Xeris Biopharma (XERS), Vir Biotechnology (VIR), Pharming Group (PHAR), and Gyre Therapeutics (GYRE). These companies are all part of the "pharmaceutical products" industry. Kodiak Sciences vs. Its Competitors GH Research CorMedix Immunome Syndax Pharmaceuticals KalVista Pharmaceuticals Replimune Group Xeris Biopharma Vir Biotechnology Pharming Group Gyre Therapeutics GH Research (NASDAQ:GHRS) and Kodiak Sciences (NASDAQ:KOD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Does the media refer more to GHRS or KOD? In the previous week, Kodiak Sciences had 1 more articles in the media than GH Research. MarketBeat recorded 7 mentions for Kodiak Sciences and 6 mentions for GH Research. Kodiak Sciences' average media sentiment score of 0.58 beat GH Research's score of 0.35 indicating that Kodiak Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GH Research 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Kodiak Sciences 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, GHRS or KOD? GH Research is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGH ResearchN/AN/A-$38.96M-$0.79-20.09Kodiak SciencesN/AN/A-$176.21M-$3.63-1.25 Do analysts recommend GHRS or KOD? GH Research currently has a consensus target price of $32.00, indicating a potential upside of 101.64%. Kodiak Sciences has a consensus target price of $9.00, indicating a potential upside of 98.68%. Given GH Research's stronger consensus rating and higher probable upside, equities analysts clearly believe GH Research is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GH Research 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Kodiak Sciences 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, GHRS or KOD? GH Research has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Kodiak Sciences has a beta of 2.28, suggesting that its share price is 128% more volatile than the S&P 500. Is GHRS or KOD more profitable? GH Research's return on equity of -19.20% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets GH ResearchN/A -19.20% -18.40% Kodiak Sciences N/A -115.71%-54.17% Do insiders and institutionals believe in GHRS or KOD? 56.9% of GH Research shares are owned by institutional investors. Comparatively, 89.1% of Kodiak Sciences shares are owned by institutional investors. 41.6% of GH Research shares are owned by insiders. Comparatively, 45.9% of Kodiak Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryGH Research beats Kodiak Sciences on 7 of the 13 factors compared between the two stocks. Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KOD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOD vs. The Competition Export to ExcelMetricKodiak SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$236.91M$2.99B$5.60B$9.11BDividend YieldN/A2.39%5.24%4.02%P/E Ratio-1.2520.5827.9620.25Price / SalesN/A291.28430.5799.61Price / CashN/A42.8637.4658.16Price / Book1.587.638.045.49Net Income-$176.21M-$55.05M$3.18B$250.27M7 Day Performance14.39%8.39%3.63%4.75%1 Month Performance23.10%5.35%4.04%7.64%1 Year Performance51.00%1.95%29.56%16.34% Kodiak Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KODKodiak Sciences4.0939 of 5 stars$4.53+0.9%$9.00+98.7%+64.1%$236.91MN/A-1.2590News CoverageGHRSGH Research1.9761 of 5 stars$15.01+0.7%$32.00+113.2%+33.4%$780.94MN/A-19.0010CRMDCorMedix2.7322 of 5 stars$11.42-1.7%$17.14+50.1%+128.5%$774.50M$43.47M51.9130Positive NewsIMNMImmunome2.0935 of 5 stars$8.69-1.7%$23.33+168.5%-33.4%$756.12M$9.04M-2.7340Positive NewsSNDXSyndax Pharmaceuticals3.0276 of 5 stars$8.73-3.0%$35.80+310.1%-59.2%$751.22M$23.68M-2.26110Analyst ForecastKALVKalVista Pharmaceuticals4.0989 of 5 stars$15.06+25.7%$24.14+60.3%+16.2%$748.78MN/A-4.05100Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap DownHigh Trading VolumeREPLReplimune Group4.0713 of 5 stars$9.65+2.7%$20.83+115.9%+10.6%$743.92MN/A-3.14210News CoverageHigh Trading VolumeXERSXeris Biopharma3.8716 of 5 stars$4.70-1.1%$6.25+33.0%+118.4%$734.99M$203.07M-15.67290News CoveragePositive NewsVIRVir Biotechnology3.6071 of 5 stars$5.27-2.6%$32.86+523.5%-38.3%$728.51M$14.30M-1.25580News CoverageAnalyst ForecastPHARPharming Group2.2567 of 5 stars$10.47-1.0%$30.00+186.5%+20.0%$719.77M$320.71M-52.35280Gap DownGYREGyre Therapeutics0.2315 of 5 stars$7.62-6.3%N/A-40.6%$714.45M$105.76M381.1940Positive News Related Companies and Tools Related Companies GHRS Competitors CRMD Competitors IMNM Competitors SNDX Competitors KALV Competitors REPL Competitors XERS Competitors VIR Competitors PHAR Competitors GYRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOD) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KOD Stock Alerts